| __timestamp | Alnylam Pharmaceuticals, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 190249000 | 85181000 |
| Thursday, January 1, 2015 | 276495000 | 135253000 |
| Friday, January 1, 2016 | 382392000 | 162297000 |
| Sunday, January 1, 2017 | 390635000 | 198442000 |
| Monday, January 1, 2018 | 505420000 | 226616000 |
| Tuesday, January 1, 2019 | 655114000 | 299726000 |
| Wednesday, January 1, 2020 | 654819000 | 335375000 |
| Friday, January 1, 2021 | 792156000 | 505748000 |
| Saturday, January 1, 2022 | 883015000 | 590453000 |
| Sunday, January 1, 2023 | 1004415000 | 849658000 |
| Monday, January 1, 2024 | 1126232000 |
Unleashing insights
In the competitive world of pharmaceuticals, innovation is the lifeblood of progress. Over the past decade, Alnylam Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc have demonstrated a steadfast commitment to research and development (R&D), a critical driver of their success.
Since 2014, Alnylam has consistently increased its R&D spending, culminating in a remarkable 428% growth by 2023. This surge underscores their dedication to pioneering RNA interference therapeutics, a cutting-edge approach in drug development.
Jazz Pharmaceuticals has also shown a robust commitment to innovation, with a 900% increase in R&D expenses over the same period. Their focus on sleep disorders and oncology has positioned them as leaders in these specialized fields.
Both companies exemplify how strategic investment in R&D can propel pharmaceutical advancements, ultimately benefiting patients worldwide.
R&D Insights: How Johnson & Johnson and Jazz Pharmaceuticals plc Allocate Funds
Amgen Inc. vs Jazz Pharmaceuticals plc: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for argenx SE and Jazz Pharmaceuticals plc
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Axsome Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for Neurocrine Biosciences, Inc. and Jazz Pharmaceuticals plc
R&D Spending Showdown: Jazz Pharmaceuticals plc vs Blueprint Medicines Corporation
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Axsome Therapeutics, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and TG Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Jazz Pharmaceuticals plc and Mesoblast Limited
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Dynavax Technologies Corporation